期刊文献+

蛋白酶体对血管平滑肌细胞凋亡及表型转换调节作用的研究进展

原文传递
导出
摘要 蛋白酶体是广泛存在于真核细胞的一种蛋白复合物,负责降解泛素分子标记的蛋白,为细胞内清除体内异常合成及损坏蛋白的重要机制之一。此外,还通过蛋白合成的转录后调解参与多种重要的细胞功能,如抗原提呈、细胞周期的调节及转录活化因子NF-KB激活等^[1]。近期研究提示蛋白酶体在心血管系统的发育分化中发挥重要作用,同时在动脉粥样硬化、血管损伤后再狭窄、心肌肥大、心肌缺血-再灌注损伤等心血管疾病中发挥重要作用,
出处 《中华普通外科杂志》 CSCD 北大核心 2014年第3期235-237,共3页 Chinese Journal of General Surgery
  • 相关文献

参考文献25

  • 1Hasselgren PO, Fischer JE. The ubiquitin-proteasome pathway : review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions [ J ]. Ann Surg, 1997,225(3) :307-316.
  • 2Willis MS, Townley-Tilson WH, Kang EY, et al. Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease[J]. Cire Res, 2010,106 ( 3 ) :463-478.
  • 3Kisselev AF, Garcia-Calvo M, Overkleeft HS, et al. The caspase- like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites [ J ]. J Biol Chem, 2003,278 ( 38 ) : 35869-35877.
  • 4Mearini G, Schlossarek S, Willis MS, et al. The ubiquitin- proteasome system in cardiac dysfunction [ J ]. Biochim Biophys Acta, 2008,1782(12) :749-763.
  • 5Herrmann J, Edwards WD, Holmes DR Jr, et al. Increased ubiquitin immunoreactivity in unstable atherosclerotic plaquesassociated with acute coronary syndromes [ J ]. J Am Coll Cardiol, 2002,40 ( 1 l ) : 1919-1927.
  • 6Herrmann J, Saguner AM, Versar/ D, et al. Chronic proteasome inhibition contributes to coronary atherosclerosis [ J 1. Circ Res, 2007,101 ( 9 ) : 865-874.
  • 7Marfella R, D'Amico M, Di Filippo C, et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment[ J]. J Am Coil Cardio, 2006,47 ( 12 ) :2444-2455.
  • 8Demasi M, Laurindo FR. Physiological and pathological role of the ubiquitin-proteasome system in the vascular smooth muscle cell[J]. Cardiovasc Res, 2012,95(2) :183-193.
  • 9Wang Q, Mora-Jensen H, Weniger MA, et al. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells[J]. Proc Natl Acad Sci U S A, 2009,106(7) :2200-2205.
  • 10Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors[ J]. PLoS One, 2009,4 ( 8 ) : e6593.

二级参考文献22

  • 1Nordon IM, Hinchliffe R J, Loftus IM, et al. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol, 2011,8:92-102.
  • 2Jones KG, Brull DJ, Brown LC,et al. Interlcukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation, 2001, 103:2260-2265.
  • 3Saraff K, Babamusta F, Cassis LA, et al. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin I1 -infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Bio1,2003,23 : 1621-1626.
  • 4Forester ND, Cruickshank SM, Scott DJ, et al. Functional characterization of T cells in abdominal aortic aneurysms. Immunology, 2005,115:262-270.
  • 5Sehonbeek U, Sukhova GK, Gerdes N, et al. Th2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol, 2002,161:499-506.
  • 6Ailawadi G, Eliason JL, Upchurch GR, Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg, 2003,38:584-588.
  • 7Boyle J J, Weissberg PL, Bennett MR. Tumor necrosis factor-ct promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vase Biol, 2003,23:1553-1558.
  • 8Choke E, Thompson MM, Dawson J, et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioseler Thromb Vase Bio1,2006 ,26 :2077-2082.
  • 9Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell,2009,16:633-647.
  • 10Wang Z, Banerjee S, Li Y, et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-KB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res, 2006,66:2778-2784.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部